Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

This is called prehabilitation or prehab. This section is about treatment for large bowel (colon) cancer that hasn't spread to another part of the body. The main treatments are surgery and ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Colon-cancer treatment Treatment varies depending on how far the cancer has advanced and where in the bowel it is, but it can include surgery, radiation therapy, chemotherapy, and immunotherapy.

More information: Scott Kopetz et al, Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial, Nature Medicine (2025). DOI: 10.1038/s41591-024-03443-3 ...

A recent analysis from a randomized clinical trial conducted by researchers at the Dana-Farber Brigham Cancer Center ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%.

This breakthrough represents a beacon of hope in the fight against pancreatic cancer and other hard-to-treat malignancies. With continued research, collaboration, and funding, this innovative ...

ctDNA can potentially be predictive for adjuvant therapy in stages II and III colon cancer ... do not clearly identify which patients need chemotherapy and which patients could do fine without ...